Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study

by Metcalfe, C, Tilling, K, Davis, M, Lane, J A, Martin, R M, Kynaston, H, Powell, P, Neal, D E, Hamdy, F, Donovan, J L
Published 2009

KIR haplotypes are associated with late-onset type 1 diabetes in European–American families

by Traherne, J A, Jiang, W, Valdes, A M, Hollenbach, J A, Jayaraman, J, Lane, J A, Johnson, C, Trowsdale, J, Noble, J A
Published 2016

Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM) for diagnosis and management of bladder outlet obstruction in men: study protocol for...

by Bailey, K., Abrams, P., Blair, P. S., Chapple, C., Glazener, C., Horwood, J., Lane, J. A., McGrath, J., Noble, S., Pickard, R., Taylor, G., Young, G. J., Drake, M. J., Lewis, A. L.
Published 2015

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study

by Catto, J W F, Robinson, M C, Albertsen, P C, Goepel, J R, Abbod, M F, Linkens, D A, Davis, M, Rosario, D J, Warren, A Y, Varma, M, Griffiths, D F, Grigor, K M, Mayer, N J, Oxley, J D, Deshmukh, N S, Lane, J A, Metcalfe, C, Donovan, J L, Neal, D E, Hamdy, F C
Published 2011

Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

by Turner, E L, Metcalfe, C, Donovan, J L, Noble, S, Sterne, J A C, Lane, J A, Avery, K N, Down, L, Walsh, E, Davis, M, Ben-Shlomo, Y, Oliver, S E, Evans, S, Brindle, P, Williams, N J, Hughes, L J, Hill, E M, Davies, C, Ng, S Y, Neal, D E, Hamdy, F C, Martin, R M
Published 2014